CHMP of EMA conveyed negative trend vote of Puma’s MA for neratinib for treating HER2-positive Breast Cancer Read more
Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more
Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH Read more